Understanding the role of placental cells in preeclampsia
Modeling Normal and Abnormal Trophoblasts
This study is looking at how certain cells in the placenta behave differently in pregnancies affected by preeclampsia, using advanced lab techniques to help us better understand this condition and hopefully find ways to improve care for pregnant people facing it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11082320 on NIH RePORTER |
What this research studies
This research investigates the abnormalities in placental trophoblasts associated with preeclampsia, a serious condition during pregnancy. It employs innovative models, including induced pluripotent stem cells and 3D trophoblast organoids, to explore how these cells develop and function in both normal and preeclamptic pregnancies. By examining the differentiation and signaling pathways of these cells, the research aims to clarify their role in the onset of preeclampsia and improve our understanding of this condition's underlying mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals, particularly those at risk for or diagnosed with preeclampsia.
Not a fit: Patients who are not pregnant or those with conditions unrelated to preeclampsia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic and therapeutic strategies for managing preeclampsia, ultimately improving outcomes for mothers and their babies.
How similar studies have performed: Previous research has shown promising results in understanding placental function through similar cellular models, indicating potential for success in this area.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Schulz, Laura Clamon — University of Missouri-Columbia
- Study coordinator: Schulz, Laura Clamon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.